financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Hold Opinion On Shares Of Caesars Entertainment, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Hold Opinion On Shares Of Caesars Entertainment, Inc.
May 1, 2024 5:59 AM

08:30 AM EDT, 05/01/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month price target by $5 to $37, based on 5.4x our 2024 EBITDA estimate and below the company's 1-year average forward EV/EBITDA multiple of 8.7x, reflecting our view that CZR is overleveraged with an EBIT/Interest Expense ratio of just 1.1x during a strong economic year in the U.S. We lower our 2024 EPS estimate by $0.60 to $0.40 and 2025 EPS estimate by $0.50 to $0.75. CZR posts normalized Q1 EPS of ($0.44) vs. $0.14, $0.38 below consensus estimates on revenues of $2.74B vs. $2.83B and $88M below estimates. By segment, Las Vegas revenues declined 4.5% Y/Y, Regional declined 1.7%, and Caesars Digital increased 18.5%. Debt remains our biggest concern as the company has repaid almost none of its debt load and refinanced a large portion in Q1. We wouldn't be surprised to see the company sell off some of its assets over the next year to pay down some of its debt. That being said, valuation has compressed significantly and we believe shares trade near fair value.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Raises Opinion On Shares Of Caesars Entertainment, Inc. To Buy From Hold
Research Alert: CFRA Raises Opinion On Shares Of Caesars Entertainment, Inc. To Buy From Hold
Mar 25, 2025
12:35 PM EDT, 03/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target of $39 is on 8.5x our 2025 EBITDA estimate and below CZR's three-year average forward EV/EBITDA multiple of 9.2x, reflecting our view of a weaker U.S. consumer...
Research Alert: CFRA Lowers Opinion On Shares Of Kb Home To Hold From Buy
Research Alert: CFRA Lowers Opinion On Shares Of Kb Home To Hold From Buy
Mar 25, 2025
11:30 AM EDT, 03/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $62, down from $81, is 8.5x our FY 25 (Nov.) EPS view of $7.26. We trim our FY 25 EPS to $7.26 from $8.71 and...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Mccormick & Company Incorporated
Research Alert: CFRA Keeps Hold Opinion On Shares Of Mccormick & Company Incorporated
Mar 25, 2025
09:20 AM EDT, 03/25/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: MKC reported decent Q1 FY 25 (Nov.) results with revenue of $1.61B (+0.2% Y/Y) in line with our estimate but $9M short of consensus, while adjusted EPS of $0.60 (-5%...
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Mar 24, 2025
04:45 PM EDT, 03/24/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $331 from $304 based on our Net Present Value (NPV) analysis. We lower our 2025 EPS estimate to -$1.62 from $0.30 our 2026 EPS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved